Sarepta Therapeutics (SRPT) Change in Inventory (2016 - 2026)

Sarepta Therapeutics' Change in Inventory history runs 11 years deep, the most recent figure standing at $69.8 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 60.67% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $193.5 million (down 62.21% YoY), while the FY2025 annual figure was $301.1 million, down 23.81% from the prior year.
• Change in Inventory was $69.8 million for Q1 2026 at Sarepta Therapeutics, up from -$18.5 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $177.4 million in Q1 2025 to a low of -$18.5 million in Q4 2025.
• Historically, Change in Inventory has averaged $56.7 million across 5 years, with a median of $59.2 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Change in Inventory soared 19675.16% in 2024, then plunged 111.43% in 2025.
• A 5-year view of Change in Inventory shows it stood at $8.9 million in 2022, then soared by 959.73% to $94.1 million in 2023, then jumped by 71.79% to $161.7 million in 2024, then slumped by 111.43% to -$18.5 million in 2025, then surged by 477.57% to $69.8 million in 2026.
• The last three Change in Inventory figures came in at $69.8 million (Q1 2026), -$18.5 million (Q4 2025), and $83.0 million (Q3 2025), per Business Quant data.